TY - JOUR AU - Klevansky, Myron AU - John, Thomas PY - 2018 TI - Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC? JF - Journal of Thoracic Disease; Vol 10, Supplement 17 (June 20, 2018): Journal of Thoracic Disease Y2 - 2018 KW - N2 - In an age of targeted therapies, the promise of eliminating non-targeted and indeed more toxic chemotherapy was considered a given until several trials challenged this assumption. UR - https://jtd.amegroups.org/article/view/21053